Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of EUR 216.62 billion. The enterprise value is 239.20 billion.
Market Cap | 216.62B |
Enterprise Value | 239.20B |
Important Dates
The last earnings date was Tuesday, February 4, 2025.
Earnings Date | Feb 4, 2025 |
Ex-Dividend Date | Mar 17, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.24% |
Shares Change (QoQ) | -0.16% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 2.53B |
Valuation Ratios
The trailing PE ratio is 13.10.
PE Ratio | 13.10 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 38.70 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 14.47 |
EV / Sales | 3.90 |
EV / EBITDA | 9.28 |
EV / EBIT | 10.98 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.86 |
Debt / EBITDA | 1.42 |
Debt / FCF | n/a |
Interest Coverage | 17.91 |
Financial Efficiency
Return on equity (ROE) is 41.69% and return on invested capital (ROIC) is 18.17%.
Return on Equity (ROE) | 41.69% |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 18.17% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 872,956 |
Profits Per Employee | 232,864 |
Employee Count | 72,000 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.33% in the last 52 weeks. The beta is 0.40, so Merck & Co.'s price volatility has been lower than the market average.
Beta (5Y) | 0.40 |
52-Week Price Change | -28.33% |
50-Day Moving Average | 92.11 |
200-Day Moving Average | 103.55 |
Relative Strength Index (RSI) | 44.52 |
Average Volume (20 Days) | 10,922 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.12 |
Income Statement
In the last 12 months, Merck & Co. had revenue of EUR 61.98 billion and earned 16.53 billion in profits. Earnings per share was 6.51.
Revenue | 61.98B |
Gross Profit | 50.11B |
Operating Income | 21.99B |
Pretax Income | 19.26B |
Net Income | 16.53B |
EBITDA | 26.02B |
EBIT | 21.99B |
Earnings Per Share (EPS) | 6.51 |
Balance Sheet
The company has 14.10 billion in cash and 36.83 billion in debt, giving a net cash position of -22.74 billion.
Cash & Cash Equivalents | 14.10B |
Total Debt | 36.83B |
Net Cash | -22.74B |
Net Cash Per Share | n/a |
Equity (Book Value) | 43.04B |
Book Value Per Share | 16.98 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 80.85%, with operating and profit margins of 35.48% and 26.68%.
Gross Margin | 80.85% |
Operating Margin | 35.48% |
Pretax Margin | 31.07% |
Profit Margin | 26.68% |
EBITDA Margin | 41.98% |
EBIT Margin | 35.48% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.89, which amounts to a dividend yield of 3.40%.
Dividend Per Share | 2.89 |
Dividend Yield | 3.40% |
Dividend Growth (YoY) | 5.09% |
Years of Dividend Growth | 7 |
Payout Ratio | n/a |
Buyback Yield | 0.24% |
Shareholder Yield | 3.63% |
Earnings Yield | 7.63% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |